Structure of Chinese Herbal-based Medicine Captured by ATP on a Human tRNA Synthetase
For approximately 2,000 years, the Chinese have been using the Chang Shan herb to treat malaria-induced fevers. A derivative of the herb's active ingredient has also been utilized in clinical trials for cancer and other therapies. Previous studies showed that the derivative, called halofuginone (HF), binds to an enzyme known as prolyl-tRNA synthetase (ProRS). Inhibition of ProRS by HF requires the additional presence of adenosine triphosphate (ATP), interestingly one of ProRS's three native substrates. Recent studies have shed new light on the structural interplay of ProRS, HF and ATP.